COVID-19 pandemic challenges: on the way to overcome obstacles in realization of PAH-specific therapy treatment goals

COVID-19 pandemic challenges: on the way to overcome obstacles in realization of PAH-specific therapy treatment goals

Our observation demonstrates a case of a 40-year-old female with idiopathic pulmonary arterial hypertension World Health Organization functional class III, who was admitted to NMRC of Cardiology repeatedly due to disease progression including dyspnea worsening and exercise tolerance decrease after p...

Full description

Bibliographic Details
Main Authors:	E. A. Rezukhina, I. Z. Korobkova, N. M. Danilov, V. V. Gramovich, T. V. Martynyuk
Format:	Article
Language:	Russian
Published:	InterMedservice 2021-11-01
Series:	Евразийский Кардиологический Журнал
Subjects:	covid-19 pulmonary arterial hypertension idiopathic pulmonary hypertension pah-specific therapy
Online Access:	https://www.heartj.asia/jour/article/view/6293

Similar Items

Patient and disease characteristics of pulmonary arterial hypertension patients for prostacyclin receptor agonist selexipag treatment initiation
by: E. A. Rezukhina, et al.
Published: (2023-03-01)

The place of tadalafil in the treatment of PAH in the light of new clinical guidelines of the Eurasian Association of Cardiologists
by: T. V. Martynyuk
Published: (2024-03-01)

Prostacyclin receptor agonist selexipag in a patient with high-risk idiopathic pulmonary arterial hypertension: a case report
by: E. A. Rezukhina, et al.
Published: (2021-09-01)

OPPORTUNITIES FOR OPTIMIZATION OF DRUG THERAPY BY ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION AND ATRIAL SEPTOSTOMY
by: V. V. Gramovich, et al.
Published: (2018-12-01)

EXPERIENCE OF IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION PATIENTS MANAGEMENT IN URAL FEDERAL DISTRICT: FEATURES OFOUTPATIENT-HOSPITAL INTERACTIONS
by: S. V. Shalaev, et al.
Published: (2019-03-01)

Possibilities of long-term effective treatment of idiopathic pulmonary arterial hypertension by replacing sildenafil with riociguat and using sequential combination therapy: case report
by: S. A. Musashaykhova, et al.
Published: (2022-12-01)

Possibility of evaluation of oxygen transport function in PAH patients on effective selexipag-based therapy
by: E. S. Allakhverdiev, et al.
Published: (2023-10-01)

Successful heart lung transplantation in patient with pulmonary capillary hemangiomatosis: case presentation
by: E. A. Rezukhina, et al.
Published: (2024-10-01)

The clinical profile of pulmonary arterial hypertension in newly diagnosed patients with connective tissue disease from the point of view of the cardiologist
by: E. A. Rezukhina, et al.
Published: (2023-05-01)

THE ROLE OF RIOCIGUAT IN THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONNECTIVE TISSUE DISEASE
by: O. Ya. Vasiltseva, et al.
Published: (2019-12-01)

Organization of pharmacological support of patients with rare diseases in moscow as exemplified by pulmonary arterial hypertension
by: M. V. Zhuravleva, et al.
Published: (2018-09-01)

ORAL ANTICOAGULANTS IN PATIENTS WITH DIFFERENT FORMS OF PULMONARY ARTERIAL HYPERTENSION, ASPECTS OF THE PROBLEM
by: S. Ye. Gratsianskaya, et al.
Published: (2017-12-01)

Assessment of the effectiveness of PAH-specific therapy, including selexipag, in patients with idiopathic pulmonary hypertension according to a comprehensive examination using Raman spectroscopy
by: E. S. Allakhverdiev, et al.
Published: (2023-11-01)

Stenosis of the trunk of the left coronary artery in idiopathic pulmonary hypertension. Case report
by: Sergei N. Ivanov, et al.
Published: (2023-02-01)

PULMONARY HYPERTENSION: DIFFICULT CASE IN CLINICAL PRACTICE
by: D. V. Madeeva, et al.
Published: (2014-07-01)

Epidemiological and clinical characteristics of pulmonary arterial hypertension in Indian patients: A hospital-based observational study
by: Mithilesh Kulkarni, et al.
Published: (2023-01-01)

Results of long-term riociguat therapy, including a switching strategy from sildenafil, in patients with pulmonary hypertension of various genesis
by: S. A. Musashaykhova, et al.
Published: (2023-11-01)

Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension (2023)
by: I. E. Chazova, et al.
Published: (2024-03-01)

Changing “portrait” of patients with newly diagnosed idiopathic pulmonary hypertension over the past two decades
by: A. M. Shariya, et al.
Published: (2024-10-01)

CASE REPORT ON THE SUCCESSFUL USE OF A NEW SELECTIVE PROSTACYCLIN IP RECEPTOR AGONIST, SELEXIPAG, IN A PATIENT WITH IDIOPATHIC PULMONARY HYPERTENSION
by: Z. S. Valieva, et al.
Published: (2019-12-01)

Pulmonary arterial hypertension: challenges and achievements 2021
by: E. A. Rezukhina, et al.
Published: (2022-03-01)

MANAGEMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN THE PANDEMIC OF A NEW CORONAVIRUS INFECTION
by: T. V. Martynyuk, et al.
Published: (2020-06-01)

The Challenge to Decide between Pulmonary Hypertension Due to Chronic Lung Disease and PAH with Chronic Lung Disease
by: Horst Olschewski
Published: (2021-02-01)

A Protocol for Fabrication and on-Chip Cell Culture to Recreate PAH-Afflicted Pulmonary Artery on a Microfluidic Device
by: Tanoy Sarkar, et al.
Published: (2022-09-01)

Cellular senescence in the pathogenesis of pulmonary arterial hypertension: the good, the bad and the uncertain
by: Elmira Safaie Qamsari, et al.
Published: (2024-08-01)

LEFT MAIN CORONARY ARTERY COMPRESSION SYNDROME IN PATIENT WITH PULMONARY ARTERIAL HYPERTENSION. FIRST CLINICAL EXPERIENCE
by: A. N. Bykov, et al.
Published: (2018-12-01)

Using PAH‐SYMPACT to assess quality of life in patients with pulmonary hypertension associated with chronic lung disease
by: Morgan E. Bailey, et al.
Published: (2024-01-01)

Role and predictive value of microRNAs 204 and 210 in the diagnosis of pulmonary arterial hypertension and the distinction between idiopathic, systemic sclerosis, and schistosomiasis-associated pulmonary arterial hypertension
by: Mark O. Dimitry, et al.
Published: (2024-06-01)

THE EFFICACY OF SILDENAFIL THERAPY IN PATIENTS WITH PULMONARY HYPERTENSION OF DIFFERENT ETIOLOGY: INFLUENCE ON THE CLINICAL, FUNCTIONAL, HEMODYNAMIC STATUS, STRUCTURE AND FUNCTION OF THE RIGHT AND LEFT HEART, RIGHT VENTRICULAR-ARTERIAL COUPLING
by: T. V. Martynyuk, et al.
Published: (2017-03-01)

Hemodynamic and Genetic Associations with the Risk of Idiopathic Pulmonary Arterial Hypertension Development in an Ethnic Cohort of Kazakhs
by: Dana Taizhanova, et al.
Published: (2024-11-01)

Lung transplantation for idiopathic pulmonary arterial hypertension: perioperational features
by: V. N. Poptsov, et al.
Published: (2019-01-01)

Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart defects in adults (2021)
by: I. E. Chazova, et al.
Published: (2022-05-01)

Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development
by: Jaydev Dave, et al.
Published: (2023-07-01)

PULMONARY ARTERIAL HYPERTENSION DIAGNOSTICS SPECIFICS IN SYSTEMIC SCLERODERMIA
by: M. A. Simakova, et al.
Published: (2016-11-01)

Idiopathic Pulmonary Hypertension and in Situ Thromboembolism: A Difficult Case in Clinical Practice
by: M. A. Us, et al.
Published: (2024-01-01)

COMPARATIVE CLINICAL CHARACTERISTICS OF PATIENTS WITH VARIOUS FORMS OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE, ACCORDING TO THE CLINICAL CLASSIFICATION
by: S. E. Gratsianskaya, et al.
Published: (2019-12-01)

Interaction of Biochemical Processes between Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension (PAH), and Coronavirus Disease 2019 (COVID-19)
by: Tian Zhe, et al.
Published: (2023-06-01)

FEATURES OF PULMONARY ARTERIAL HYPERTENSION IN THE RUSSIAN REGISTER
by: O. A. Arkhipova, et al.
Published: (2014-12-01)

Pulmonary Vasodilator Therapy Is Associated with Decreased Mortality in Patients with Chronic Lung Disease and Severe Pulmonary Hypertension
by: Olivia Schanz, et al.
Published: (2024-03-01)

Vasoreactivity testing in pulmonary hypertension associated with congenital heart disease
by: A. A. Shmalts, et al.
Published: (2022-10-01)